Clinical Trial Update: Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 trial evaluating the safety and efficacy of ruxolitinib cream for non-sclerotic cutaneous chronic graft-versus-host d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non-sclerotic Cutaneous Chronic Graft-versus-host Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-10